Tag: NYSE:BIO

  • Watch List: AstraZeneca plc (ADR) (NYSE:AZN), Boston Scientific Corporation (NYSE:BSX), Bio-Rad Laboratories (NYSE:BIO), Danaher Corporation (NYSE:DHR), Siemens AG (ADR) (OTCMKTS:SIEGY)

    AstraZeneca plc (ADR) (NYSE:AZN)‘s stock had its “hold” rating reiterated by Beaufort Securities in a research note issued on Monday. AstraZeneca plc (ADR) (NYSE:AZN) net profit margin is 8.00% and weekly performance is 0.85%. On last trading day company shares ended up $73.74. Analysts mean target price for the company is $73.78. AstraZeneca plc (ADR) (NYSE:AZN) distance from 50-day simple moving average (SMA50) is 2.28%.

    On June 11, Boston Scientific Corporation (NYSE:BSX) Announced One-Year Results In The VANTAGE Clinical Study Evaluating The Verciseâ„¢ DBS System. Patients with Parkinson’s disease (PD) treated with the Boston Scientific Corporation (NYSE: BSX) Vercise™ Deep Brain Stimulation (DBS) System demonstrated a highly significant and consistent improvement in motor scores, according to the latest one-year data. Boston Scientific Corporation (NYSE:BSX) shares advanced 0.94% in last trading session and ended the day on $12.92. Gross Margin is 70.20% and its return on assets is 2.20%. Boston Scientific Corporation (NYSE:BSX) quarterly performance is -0.46%.

    On June 13, Bio-Rad Laboratories, Inc. (NYSE:BIO) has announced the launch of its SsoAdvanced™ PreAmp Supermix and PrimePCR™ PreAmp Assays. The supermix is formulated to permit unbiased, target-specific preamplification of cDNA or genomic DNA (gDNA), which allows researchers to stretch their limited nucleic acid samples. PrimePCR PreAmp assays are wet-lab validated preamplification primers that work seamlessly with the supermix to ensure optimal preamplification for real-time PCR. Bio-Rad Laboratories, Inc. (NYSE:BIO) shares moved down -0.33% in last trading session and was closed at $120.10, while trading in range of $119.00 – $120.84. Bio-Rad Laboratories, Inc. (NYSE:BIO) year to date (YTD) performance is -2.84%.

    On June 14, In the past six months, shares of Danaher Corporation (NYSE:DHR) —a Washington, D.C.-based conglomerate whose interests span a wide swath of industries including electronic measuring equipment, medical diagnostic instruments, and water-treatment systems, among others—have shown uncharacteristic weakness amid a slowdown in its deal making, on which it depends heavily for growth. Danaher Corporation (NYSE:DHR) ended the last trading day at $80.07. Company weekly volatility is calculated as 0.67% and price to cash ratio as 16.74. Danaher Corporation (NYSE:DHR) showed a negative weekly performance of -0.60%.

    Engineering giants Siemens AG (ADR) (OTCMKTS:SIEGY) of Germany and Mitsubishi Heavy Industries of Japan on Monday jointly offered to buy parts of France’s Alstom and start a long-term partnership, a move that could derail a competing bid by General Electric. Siemens AG said it is offering $5.3 billion to acquire Alstom’s gas business entirely, including related service contracts. Mitsubishi would purchase a 10 percent stake of Alstom and inject $4.2 billion into the company. Siemens AG (ADR) (OTCMKTS:SIEGY) On last trading day company shares ended up $134.33 .